Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Vedolizumab Antibody (5Q402)

😃Good
Catalog No. TMAS-00119
Alias MLN-002, MLN002, MLN-0002, LDP-02, LDP02, Entyvio

Anti-Vedolizumab Antibody (5Q402) is a Rabbit antibody targeting Vedolizumab. Anti-Vedolizumab Antibody (5Q402) can be used in ELISA, Sandwich ELISA.

Anti-Vedolizumab Antibody (5Q402)

Anti-Vedolizumab Antibody (5Q402)

😃Good
Catalog No. TMAS-00119Alias MLN-002, MLN002, MLN-0002, LDP-02, LDP02, Entyvio
Anti-Vedolizumab Antibody (5Q402) is a Rabbit antibody targeting Vedolizumab. Anti-Vedolizumab Antibody (5Q402) can be used in ELISA, Sandwich ELISA.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
40 μg$6097-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-Vedolizumab Antibody (5Q402) is a Rabbit antibody targeting Vedolizumab. Anti-Vedolizumab Antibody (5Q402) can be used in ELISA, Sandwich ELISA.
SynonymsMLN-002, MLN002, MLN-0002, LDP-02, LDP02, Entyvio
Ig Type
IgG, κ
Clone
5Q402
Specificity
Vedolizumab
Application
Recommended Dose
ELISA: 0.01-1 µg/ml; Sandwich ELISA: 0.5-2 μg/ml
Antibody Type
Monoclonal
Host SpeciesRabbit
PurificationProtein A affinity column
AppearanceLyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
FormulationLyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
Research BackgroundVedolizumab is a humanized monoclonal antibody used primarily for the treatment of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. The drug functions by specifically targeting the integrin α4β7, a molecule that facilitates the migration of white blood cells into the gastrointestinal (GI) tract. By blocking this interaction, Vedolizumab reduces inflammation within the GI tract, providing relief from the symptoms associated with IBD. The drug is administered intravenously and is known for its gut-selective mechanism of action, which limits systemic immune suppression and focuses treatment effects on the GI tract. It was approved by the FDA in 2014 and is marketed under the brand name Entyvio.
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Vedolizumab
Chemical Properties
Stability & Storage
Stability & StorageThe lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-Vedolizumab Antibody (5Q402) | purchase Anti-Vedolizumab Antibody (5Q402) | Anti-Vedolizumab Antibody (5Q402) cost | order Anti-Vedolizumab Antibody (5Q402)